Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Biogen is set for big gains on slate of trial data releases, JPMorgan says

Biogen will release data from clinical trials for a few of its investigational treatments over the next few months, which should boost its shares, per JPMorgan.

We haven't written up this one. CNBC has the full story — the link below goes straight to it.

Also reported by 2 other outlets

Read the original at cnbc.com →

More in Finance & Markets

More from Monday 12 October →